Maurer, MS;
Schwartz, JH;
Gundapaneni, B;
Elliott, P;
Merlini, G;
Cruz, MW;
Kristen, AV;
... Rapezzi, C; + view all
(2018)
Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary Results.
Presented at: 22nd Annual Scientific Meeting of the Heart Failure Society of America (HFSA), Nashville, TN, USA.
Preview |
Text
Elliott_AAHFN19 ATTR-ACT encore abstract 20181130.pdf - Accepted Version Download (141kB) | Preview |
| Type: | Conference item (Presentation) |
|---|---|
| Title: | Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary Results |
| Event: | 22nd Annual Scientific Meeting of the Heart Failure Society of America (HFSA) |
| Location: | Nashville, TN, USA |
| Dates: | 15-18 September 2018 |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.cardfail.2018.11.008 |
| Publisher version: | https://doi.org/10.1016/j.cardfail.2018.11.008 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Clinical Science |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10069110 |
Archive Staff Only
 |
View Item |
